Oghma Partners is pleased to announce its role as exclusive financial adviser to Cargill BVBA in relation to the following transaction, which was completed on 6 December 2012:
Cargill completes sale of its cultures and enzymes business to DSM
6 December 2012: Cargill has completed the sale of its cultures and enzymes business to Royal DSM. All antitrust clearances have been obtained and the transaction was completed on 6 December 2012.
Note to editors: This transaction was signed and announced on 26 October 2012. Cargill BVBA announced at that time that it was selling its cultures and enzymes business to Royal DSM, the global life sciences and materials sciences company, in an all cash transaction for a total enterprise value of €85 million. This sale is in line with Cargill’s strategy to re-focus its texturizing business and concentrate on product lines that are adjacent to the company’s core activities and where it can be a leading or relevant player in the marketplace.
The full press release can be downloaded here.
